Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 108

1.

Prior chronic clopidogrel therapy is associated with increased adverse events and early stent thrombosis.

Asher E, Fefer P, Sabbag A, Herscovici R, Regev E, Mazin I, Shlomo N, Zahger D, Atar S, Hammerman H, Polak A, Beigel R, Matetzky S; Platelets and Thrombosis in Sheba Study Group.

Thromb Haemost. 2016 Jan;115(2):433-8. doi: 10.1160/TH15-05-0384. Epub 2015 Oct 8.

PMID:
26446379
2.

Heart failure in patients with diabetes undergoing primary percutaneous coronary intervention.

Massalha S, Luria L, Kerner A, Roguin A, Abergel E, Hammerman H, Boulos M, Dragu R, Kapeliovich MR, Beyar R, Nikolsky E, Aronson D.

Eur Heart J Acute Cardiovasc Care. 2016 Oct;5(6):455-462. Epub 2015 Jul 30.

PMID:
26228449
3.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators.

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.

4.

Pulmonary arterial capacitance in patients with heart failure and reactive pulmonary hypertension.

Dragu R, Rispler S, Habib M, Sholy H, Hammerman H, Galie N, Aronson D.

Eur J Heart Fail. 2015 Jan;17(1):74-80. doi: 10.1002/ejhf.192. Epub 2014 Nov 11.

5.

Impact of functional mitral regurgitation on right ventricular function and outcome in patients with right ventricular infarction.

Yalonetsky S, Eden H, Lessick J, Kapeliovich M, Dragu R, Mutlak D, Carasso S, Reisner S, Agmon Y, Hammerman H, Aronson D.

Am J Cardiol. 2014 Jul 1;114(1):36-41. doi: 10.1016/j.amjcard.2014.04.004. Epub 2014 Apr 16.

PMID:
24819897
6.

Left ventricular function and functional recovery early and late after myocardial infarction: a prospective pilot study comparing two-dimensional strain, conventional echocardiography, and radionuclide myocardial perfusion imaging.

Carasso S, Agmon Y, Roguin A, Keidar Z, Israel O, Hammerman H, Lessick J.

J Am Soc Echocardiogr. 2013 Nov;26(11):1235-44. doi: 10.1016/j.echo.2013.07.008. Epub 2013 Aug 20.

PMID:
23972489
7.

Chest pain unit in an internal medicine department: comparison of a year with the facility to a year without.

Hamoud S, Mahamid R, Halabi M, Lessick J, Abbadi S, Shreter R, Keidar Z, Aronson D, Hammerman H, Hayek T.

Isr Med Assoc J. 2013 Feb;15(2):79-84.

8.

The relation between serum phosphorus levels and clinical outcomes after acute myocardial infarction.

Aronson D, Kapeliovich M, Hammerman H, Dragu R.

PLoS One. 2013;8(3):e58348. doi: 10.1371/journal.pone.0058348. Epub 2013 Mar 11.

9.

Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression.

Blich M, Golan A, Arvatz G, Sebbag A, Shafat I, Sabo E, Cohen-Kaplan V, Petcherski S, Avniel-Polak S, Eitan A, Hammerman H, Aronson D, Axelman E, Ilan N, Nussbaum G, Vlodavsky I.

Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):e56-65. doi: 10.1161/ATVBAHA.112.254961. Epub 2012 Nov 15.

10.

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.

Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva-Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR, Oto A, Tseng CD, Merkely B, Gasparovic V, Corbalan R, Cinteză M, McLendon RC, Winters KJ, Brown EB, Lokhnygina Y, Aylward PE, Huber K, Hochman JS, Ohman EM; TRILOGY ACS Investigators.

N Engl J Med. 2012 Oct 4;367(14):1297-309. doi: 10.1056/NEJMoa1205512. Epub 2012 Aug 25.

11.

Clopidogrel Therapy Discontinuation Following Drug Eluting Stent Implantation in Real World Practice in Israel.

Blich M, Shwiri TZ, Petcherski S, Osherov AB, Hammerman H.

Cardiol Res. 2012 Apr;3(2):67-72. doi: 10.4021/cr146w. Epub 2012 Mar 20.

12.

Vorapaxar in the secondary prevention of atherothrombotic events.

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA; TRA 2P–TIMI 50 Steering Committee and Investigators.

N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24.

13.

Utility of pulmonary hypertension for the prediction of heart failure following acute myocardial infarction.

Mutlak D, Lessick J, Carasso S, Kapeliovich M, Dragu R, Hammerman H, Agmon Y, Aronson D.

Am J Cardiol. 2012 May 1;109(9):1254-9. doi: 10.1016/j.amjcard.2011.12.035. Epub 2012 Feb 3.

PMID:
22306210
14.

Multidetector computed tomography predictors of late ventricular remodeling and function after acute myocardial infarction.

Lessick J, Abadi S, Agmon Y, Keidar Z, Carasso S, Aronson D, Ghersin E, Rispler S, Sebbag A, Israel O, Hammerman H, Roguin A.

Eur J Radiol. 2012 Oct;81(10):2648-57. doi: 10.1016/j.ejrad.2011.12.016. Epub 2011 Dec 30.

PMID:
22209631
15.

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.

Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW; TRACER Investigators.

N Engl J Med. 2012 Jan 5;366(1):20-33. doi: 10.1056/NEJMoa1109719. Epub 2011 Nov 13.

16.

Restrictive left ventricular filling pattern and risk of new-onset atrial fibrillation after acute myocardial infarction.

Aronson D, Mutlak D, Bahouth F, Bishara R, Hammerman H, Lessick J, Carasso S, Dabbah S, Reisner S, Agmon Y.

Am J Cardiol. 2011 Jun 15;107(12):1738-43. doi: 10.1016/j.amjcard.2011.02.334. Epub 2011 Apr 15.

PMID:
21497781
17.

Modelling the long QT syndrome with induced pluripotent stem cells.

Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, Feldman O, Gepstein A, Arbel G, Hammerman H, Boulos M, Gepstein L.

Nature. 2011 Mar 10;471(7337):225-9. doi: 10.1038/nature09747. Epub 2011 Jan 16.

PMID:
21240260
18.

Incidence, predictors and outcome of drug-eluting stent thrombosis in real-world practice.

Blich M, Zeidan-Shwiri T, Petcherski S, Osherov A, Hammerman H.

J Invasive Cardiol. 2010 Oct;22(10):461-4.

19.

Relationship of functional mitral regurgitation to new-onset atrial fibrillation in acute myocardial infarction.

Bahouth F, Mutlak D, Furman M, Musallam A, Hammerman H, Lessick J, Dabbah S, Reisner S, Agmon Y, Aronson D.

Heart. 2010 May;96(9):683-8. doi: 10.1136/hrt.2009.183822.

PMID:
20424149
20.

Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on renal function in patients with ST-segment elevation myocardial infarction treated with primary or rescue percutaneous coronary intervention.

Osherov AB, Roguin A, Aronson D, Grenadier E, Kerner A, Boulus M, Kapeliovich M, Hani A, Hammerman H, Beyar R, Nikolsky E.

EuroIntervention. 2009 Nov;5(5):604-9.

PMID:
20142182

Supplemental Content

Loading ...
Support Center